Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Wages, Salaries and Other
Ratios

Century Therapeutics (IPSC) Leases (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Leases for 4 consecutive years, with $16.1 million as the latest value for Q4 2025.

  • Quarterly Leases fell 43.78% to $16.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.1 million through Dec 2025, down 43.78% year-over-year, with the annual reading at $16.1 million for FY2025, 43.78% down from the prior year.
  • Leases for Q4 2025 was $16.1 million at Century Therapeutics, down from $16.6 million in the prior quarter.
  • The five-year high for Leases was $29.5 million in Q3 2022, with the low at $11.7 million in Q1 2022.
  • Average Leases over 4 years is $24.2 million, with a median of $26.4 million recorded in 2023.
  • The sharpest move saw Leases surged 141.71% in 2023, then tumbled 43.78% in 2025.
  • Over 4 years, Leases stood at $28.9 million in 2022, then fell by 29.6% to $20.4 million in 2023, then surged by 40.88% to $28.7 million in 2024, then crashed by 43.78% to $16.1 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $16.1 million, $16.6 million, and $27.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.